Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06215222

Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

We will sample intestinal microbiota using a microbiome sampling capsule in Healthy, Irritable Bowel Syndrome (IBS), and Functional Gastrointestinal Disease.

Conditions

Interventions

TypeNameDescription
OTHERMicrobiota SamplingWe will sample the Saliva, Feces, and intestinal microbiome for genetic microbiome analysis and bacterial isolation

Timeline

Start date
2023-11-16
Primary completion
2025-12-01
Completion
2026-12-01
First posted
2024-01-22
Last updated
2024-01-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06215222. Inclusion in this directory is not an endorsement.

Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease (NCT06215222) · Clinical Trials Directory